Navigation Links
100,000 Bird Flu Vaccine Doses to Be Destroyed

In the next couple of months, 100,000 doses of the country's first vaccine against bird flu will be destroyed because the laboratory that developed it has found no takers //and the expiry date is fast approaching.

It was in July last year that the High Security Animal Disease Laboratory (HSADL) here developed India's first vaccine against bird flu. It had preserved about 100,000 doses of the vaccine, each costing just 27 paise.

But no drug manufacturing company has contacted the research institute so far to buy either these doses or the formula for commercial use, an official of the institute said on condition of anonymity.

"We are now left with no option but to destroy them after 10 weeks or so since the total life of the doses is one year. They would turn ineffective after 12 months from the date of their preparation," he rued.

Talking about the vaccine's efficacy, he said: "The vaccine can be used immediately after a bird flu outbreak to control the spread of the virus as well as for vaccination in anticipation of an outbreak."

"The immune response is good and the protection offered by the vaccine has been found to be above 90 percent. The protection should last up to six months for hens. For a broiler it needs to be administered only once."

HSADL, which is equipped with the technique of identifying the avian influenza virus among poultry, tested thousands of bird samples including droppings of migratory birds last year after the first strains of the deadly H5N1 virus were detected in western Madhya Pradesh, Gujarat and Maharashtra.

"The Indian Council of Agricultural Research entrusted us with the job of developing the vaccine soon after the first outbreak of the disease in February 2006 and also promptly provided us Rs.80 million to help us accomplish the challenging task," said HSADL Joint Director H.K. Pradhan.

Pradhan and his special team of scientists swung into act ion, toiling day and night, and developed the vaccine in less than six months after the outbreak.

"The cost of the vaccine has been worked out at 27 paise per dose. It is expected to go up to 35 paise including the trader's profit and cost of transportation. But it will be for the company manufacturing the vaccine to decide on the selling price," Pradhan said.

Source-IANS
'"/>




Related medicine news :

1. Free AIDS Treatment For 100,000 Patients: Indian Govt
2. Hospital Trust Fined £100,000 after Patient Deat
3. Jolie-Pitt Donate $100,000 for Sudan Hospital
4. Vaccine to quit smoking?
5. First Vaccine Designed for Africa Cleared for Testing in Humans
6. Vaccine for Alzheimer’s diseas
7. Health Officials Recommend Flu Vaccine
8. Smallpox Vaccine May Help Fight Cervical Cancer
9. Panacea Biotech To Market Anthrax Vaccine
10. New Prostate Cancer Vaccine Shows Promise
11. Drug Firm Offers to Donate Smallpox Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Miami native ... as a dentist. , “I could have never imagined back in 1991 that this ... said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has pioneered implant ...
(Date:4/26/2017)... ST. LOUIS (PRWEB) , ... April 26, 2017 ... ... is designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping ... an economic alternative to dairy proteins, providing direct cost savings as well as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... cream that’s the first in a new class of photodynamic cosmetics (PDC). , ... of skin, visibly reduce outward signs of aging, and minimize the appearance of ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology: